Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Thu, 22 Feb 2018 13:27:40 EST

Copyright: Copyright: (C) Marketwired
 



Venous Lake Treatment is now being offered by Dr. Amir Bajoghli and the Skin and Laser Surgery Center

Thu, 22 Feb 2018 12:56:58 EST

MCLEAN, VA--(Marketwired - February 22, 2018) - Dr. Amir Bajoghli and the Skin and Laser Surgery Center of McLean, Virginia now offer the latest in treatments for a condition known as "venous lake".




Relevium Commences Trading on OTCQB

Tue, 20 Feb 2018 10:56:23 EST

MONTREAL, QUEBEC--(Marketwired - Feb. 20, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce that it has commenced trading on the OTCQB under the symbol RLLVF




Motus GI Announces NASDAQ Closing Bell Ceremony

Tue, 20 Feb 2018 08:00:00 EST

Closing Bell Ceremony today from 3:45 PM - 4PM EST




Motus GI Announces Closing of Initial Public Offering

Fri, 16 Feb 2018 16:05:00 EST

FORT LAUDERDALE, FL--(Marketwired - February 16, 2018) - Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus" or the "Company"), a medical technology company dedicated to improving endoscopy outcomes and experiences, announced today the closing of its initial public offering of 3,500,000 shares of its common stock at a public offering price of $5.00 per share, with gross proceeds of $17.5 million. Additionally, Motus has granted the underwriters a 30-day option to purchase an additional 525,000 shares of its common stock at the initial public offering price, less the underwriting discount and commissions, to cover over-allotments.




Relevium Announces 2018 AGM Results

Fri, 16 Feb 2018 15:38:03 EST

MONTREAL, QUEBEC--(Marketwired - Feb. 16, 2018) - Relevium Technologies Inc. (TSX VENTURE:RLV)(OTCQB:RLLVF)(FRANKFURT:6BX) (the "Company" or "Relevium"), is pleased to announce the positive results from its annual and special meeting held on February 15, 2018 in Montréal, Canada (the "AGM").